NGL Fine-Chem Limited (NGLFINE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs167.72 Million ≈ $1.81 Million USD) by net assets (Rs3.00 Billion ≈ $32.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NGL Fine-Chem Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

NGL Fine-Chem Limited - Cash Flow Conversion Efficiency Trend (2009–2026)

This chart illustrates how NGL Fine-Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NGL Fine-Chem Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NGL Fine-Chem Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hamilton Beach Brands Holding Co Class A
NYSE:HBB
0.018x
Trivium Real Estate Socimi SA
MC:YTRI
0.092x
Security National Financial
NASDAQ:SNFCA
80.269x
Go Fashion (India) Limited
NSE:GOCOLORS
0.138x
Next PLC
LSE:NXT
0.222x
KIP Real Estate Investment Trust
KLSE:5280
0.021x
Coca Cola HBC AG
LSE:CCH
0.256x
LB Semicon Inc
KQ:061970
0.045x

Annual Cash Flow Conversion Efficiency for NGL Fine-Chem Limited (2009–2026)

The table below shows the annual cash flow conversion efficiency of NGL Fine-Chem Limited from 2009 to 2026. For the full company profile with market capitalisation and key ratios, see market value of NGL Fine-Chem Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs3.29 Billion
≈ $35.60 Million
Rs395.40 Million
≈ $4.28 Million
0.120x -5.31%
2025-03-31 Rs2.82 Billion
≈ $30.54 Million
Rs358.22 Million
≈ $3.87 Million
0.127x +62.77%
2024-03-31 Rs2.63 Billion
≈ $28.40 Million
Rs204.65 Million
≈ $2.21 Million
0.078x -50.85%
2023-03-31 Rs2.23 Billion
≈ $24.07 Million
Rs352.86 Million
≈ $3.82 Million
0.159x +133.07%
2022-03-31 Rs2.03 Billion
≈ $21.98 Million
Rs138.25 Million
≈ $1.50 Million
0.068x -61.59%
2021-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs273.54 Million
≈ $2.96 Million
0.177x -14.36%
2020-03-31 Rs989.61 Million
≈ $10.70 Million
Rs204.64 Million
≈ $2.21 Million
0.207x +115.34%
2019-03-31 Rs921.23 Million
≈ $9.96 Million
Rs88.47 Million
≈ $956.76K
0.096x -69.07%
2018-03-31 Rs720.42 Million
≈ $7.79 Million
Rs223.65 Million
≈ $2.42 Million
0.310x +84.86%
2017-03-31 Rs585.12 Million
≈ $6.33 Million
Rs98.26 Million
≈ $1.06 Million
0.168x -11.71%
2016-03-31 Rs442.15 Million
≈ $4.78 Million
Rs84.10 Million
≈ $909.54K
0.190x -16.82%
2015-03-31 Rs328.16 Million
≈ $3.55 Million
Rs75.04 Million
≈ $811.54K
0.229x +1990.49%
2014-03-31 Rs245.44 Million
≈ $2.65 Million
Rs-2.97 Million
≈ $-32.11K
-0.012x -932.61%
2013-03-31 Rs200.15 Million
≈ $2.16 Million
Rs-234.46K
≈ $-2.54K
-0.001x -101.43%
2012-03-31 Rs171.06 Million
≈ $1.85 Million
Rs14.01 Million
≈ $151.47K
0.082x -66.15%
2011-03-31 Rs160.59 Million
≈ $1.74 Million
Rs38.85 Million
≈ $420.12K
0.242x +140.92%
2010-03-31 Rs136.48 Million
≈ $1.48 Million
Rs13.70 Million
≈ $148.20K
0.100x +413.97%
2009-03-31 Rs109.35 Million
≈ $1.18 Million
Rs-3.50 Million
≈ $-37.82K
-0.032x --

About NGL Fine-Chem Limited

NSE:NGLFINE India Drug Manufacturers - General
Market Cap
$203.47 Million
Rs18.81 Billion INR
Market Cap Rank
#16577 Global
#861 in India
Share Price
Rs3045.40
Change (1 day)
+3.93%
52-Week Range
Rs995.00 - Rs3109.30
All Time High
Rs3109.30
About

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosph… Read more